Dissolving Microneedle Membrane Composition for Flat Demolding

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing microneedle patches with dissolving microneedles face issues such as membrane curling and unflatness during preparation, leading to poor demoldability and increased breakage, which affects drug delivery efficiency.

Innovation Solution

A membrane composition comprising polyvinylpyrrolidone K30, polyvinylpyrrolidone K90, and mini-hyaluronic acid in specific proportions, ensuring a flat surface and easy demolding, with microneedles ranging from 100 to 1500 microns in height, enhancing dissolution rate and drug delivery.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If dissolving microneedles are used, then drug delivery efficiency is improved and risk of drug accumulation is reduced, but membrane surface curling and unflatness occur during preparation

Engineering Contradiction:
Improvedrug delivery rateVSAvoidmembrane surface flatness
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The patent changes the material composition parameters by using polyvinylpyrrolidone K30 and K90 with specific molecular weights and ratios (9-50 wt% K30, 40-90 wt% K90), along with mini-hyaluronic acid (0.09-9 wt%), to achieve both flat membrane surface and high dissolution rate without the drawbacks of conventional dissolving microneedles

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent creates a composite material system combining polyvinylpyrrolidone K30, polyvinylpyrrolidone K90, and mini-hyaluronic acid in specific proportions, where the synergistic interaction between these materials achieves both manufacturing precision (flat surface) and productivity (high dissolution rate)

Inventive Principle:
Principle #40Composite materials

2Productivity

If dissolving microneedles are used, then drug delivery function is enhanced, but demoldability deteriorates due to poor releasability

Engineering Contradiction:
Improvedrug delivery rateVSAvoiddemoldability
Core Design Contradiction:
ProductivityVSEase of manufacture

Solution Approach 1:

The patent modifies the material parameters by selecting specific ratios of polyvinylpyrrolidone K30 (9-50 wt%) and K90 (40-90 wt%), combined with mini-hyaluronic acid (0.09-9 wt%), to achieve optimal balance between drug delivery performance and ease of demolding during preparation

Inventive Principle:
Principle #35Parameter changes

3Reliability

If dissolving microneedles are used, then risk of microneedle breakage in skin is reduced, but membrane breakage increases during preparation

Engineering Contradiction:
Improvemicroneedle integrity in skinVSAvoidmembrane integrity during preparation
Core Design Contradiction:
ReliabilityVSManufacturing precision

Solution Approach 1:

The patent optimizes the material composition parameters with polyvinylpyrrolidone K30 (9-50 wt%), polyvinylpyrrolidone K90 (40-90 wt%), and mini-hyaluronic acid (0.09-9 wt%) to achieve both membrane integrity during preparation (reducing breakage) and microneedle integrity in skin (preventing skewing or breakage)

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The membrane maintains a flat and non-curling surface during preparation, facilitating easy demolding and achieving high dissolution rates, enabling accurate and painless delivery of active ingredients.

Implementation Method 1

penetrates into the stratum corneum of the skin through microneedles

Methodology Applied
Scientific EffectMechanical penetration: Mechanical Force

Implementation Method 2

the microneedle patch with dissolving microneedles needs to undergo mold filling, drying, demolding

Methodology Applied
Scientific EffectDissolution: Solvation

Data Source

PatentUS20250222243A1Instant membrane
Publication Date: 2025.07.10 DARWIN PRECISIONS CORP
  • US20250222243A1 patent drawing

AI summary

An instant membrane includes a base layer and a microneedle layer. The base layer has a surface. The microneedle layer is disposed on the surface of the base layer and has a plurality of microneedles. The materials of the base layer and the microneedle layer include: 9 wt %-50 wt % polyvinylpyrrolidone K30, 40 wt %-90 wt % polyvinylpyrrolidone K90 and 0.09 wt %-9 wt % mini-hyaluronic acid.